Cargando…
OR18-5 A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
OBJECTIVES: Vosoritide is a C-type natriuretic peptide analog which binds its receptor on chondrocytes, leading to increased chondrocyte proliferation and differentiation via its inhibition of the ERK1/2-MAPK pathway. It was recently approved for increasing linear growth in children with achondropla...
Autores principales: | Boucher, Kimberly, Dham, Niti, Kanakatti Shankar, Roopa, McCarthy, Tara, Merchant, Nadia, Zhang, Anqing, Dauber, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625806/ http://dx.doi.org/10.1210/jendso/bvac150.1282 |
Ejemplares similares
-
SAT-LB18 A Randomized Controlled Trial of Vosoritide in Children With Achondroplasia
por: Savarirayan, Ravi, et al.
Publicado: (2020) -
LBMON196 A Randomized Controlled Trial Of Vosoritide In Infants And Toddlers With Achondroplasia
por: Savarirayan, Ravi, et al.
Publicado: (2022) -
RF02 | PSAT119 AMH and Spontaneous Puberty in a Diverse US Turner Syndrome Clinic Cohort: A Cross-sectional study
por: Bustamante, Victoria, et al.
Publicado: (2022) -
OR07-6 Integrating Targeted Bioinformatic Searches of the Electronic Health Records and Genomic Testing Identifies a Molecular Diagnosis in Three Patients with Undiagnosed Short Stature
por: Cabrera Salcedo, Catalina, et al.
Publicado: (2019) -
Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study
por: Savarirayan, Ravi, et al.
Publicado: (2021)